Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.32) by 3.13 percent. This is a 60.26 percent increase over losses of $(0.78) per share from the same period last year. The company reported quarterly sales of $254.560 million which missed the analyst consensus estimate of $254.978 million by 0.16 percent. This is a 5.77 percent increase over sales of $240.678 million the same period last year.